Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 3897863 | HLA (HLA) | cancers | NA | NA | NA | unclassified | |
| in a study of the acceptable limits of hla incompatibility, 105 consecutive patients with hematologic cancers who received marrow grafts from haploidentical donors (study group) were compared with 728 similar patients concurrently receiving grafts from hla genotypically identical siblings (control group). | |||||||
| 3905427 | HLA (HLA) | transplantation | NA | cyclophosphamide | NA | unclassified | |
| transplantation of hla-haploidentical t-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection. | |||||||
| 3905427 | HLA (HLA) | leukemia | NA | cyclophosphamide | NA | unclassified | |
| transplantation of hla-haploidentical t-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection. | |||||||
| 3905427 | HLA IDENTICAL (HLA-IDENTICAL) | graft-versus-host disease | NA | cyclophosphamide | NA | unclassified | |
| in an effort to minimize graft-versus-host disease, marrow was depleted of t-lymphocytes in vitro with monoclonal anti-t-cell antibody and complement prior to infusion for seven of 19 recipients of marrow from hla-identical, mlc-nonreactive siblings, and for all 22 recipients of marrow from mlc-reactive hla-haploidentical donors. | |||||||
| 3914747 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | unclassified | |
| marrow transplantation is effective treatment for a number of hematological diseases in patients under the age of 50 who have an hla-identical sibling donor. | |||||||
| 3914747 | HLA IDENTICAL (HLA-IDENTICAL) | hematological diseases | NA | NA | NA | unclassified | |
| marrow transplantation is effective treatment for a number of hematological diseases in patients under the age of 50 who have an hla-identical sibling donor. | |||||||
| 3914747 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | negation | |
| marrow transplantation has been limited by the fact that many patients do not have hla-identical siblings and very few have monozygotic twins. | |||||||
| 3916499 | HLA-DR (HLA-DR) | transplantation | NA | NA | NA | positive | |
| an increase in the concentration of hla-dr on the vascular endothelium was detected shortly after transplantation. | |||||||
| 3916499 | HLA-DR (HLA-DR) | necrosis | NA | NA | NA | unclassified | |
| vascular endothelial cell hla-dr antigen and myocyte necrosis in human allograft rejection. | |||||||
| 3916499 | HLA-DR (HLA-DR) | necrosis | NA | NA | NA | unclassified | |
| low concentrations of endothelial dr were rarely (1/13) associated with myocyte necrosis. | |||||||
Copyright 2024